Article Text

PDF
Correspondences
T1 mapping with cardiovascular magnetic resonance: an emerging clinical biomarker
  1. David P Ripley1,
  2. Subhi E Akleh2,
  3. Alison F Lee1
  1. 1Department of Cardiology, Northumbria Healthcare NHS Foundation Trust, North Tyneside Hospital, North Shields, UK
  2. 2Department of Cardiology, Freeman Hospital, Newcastle-upon-Tyne, UK
  1. Correspondence to Dr David P Ripley, Department of Cardiology, Northumbria Healthcare NHS Foundation Trust, North Tyneside Hospital, Rake Lane, North Shields, NE29 8NH, UK; david.ripley{at}northumbria-healthcare.nhs.uk

Statistics from Altmetric.com

To the Editor We read with great interest the article by Canepa et al1 regarding the educational review on distinguishing ventricular septal bulge (VSB) versus hypertrophic cardiomyopathy (HCM). The authors recognise the increasingly established role of cardiovascular magnetic resonance (CMR) …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles